- Home
- PRME vs CNC Comparison
PRME vs CNC Comparison
Compare PRME & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRME | CNC |
|---|---|---|
| Founded | 2019 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 18.7B |
| IPO Year | 2022 | 2001 |
Fundamental Metrics
Financial Performance| Metric | PRME | CNC |
|---|---|---|
| Price | $3.50 | $40.41 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 17 |
| Target Price | $6.42 | ★ $40.06 |
| AVG Volume (30 Days) | 3.8M | ★ 6.0M |
| Earning Date | 11-07-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,977,000.00 | ★ $167,680,000,000.00 |
| Revenue This Year | $111.80 | $32.54 |
| Revenue Next Year | N/A | $0.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 647.13 | 14.57 |
| 52 Week Low | $1.11 | $25.08 |
| 52 Week High | $6.94 | $66.81 |
Technical Indicators
Market Signals| Indicator | PRME | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 40.00 | 60.17 |
| Support Level | $3.61 | $38.58 |
| Resistance Level | $4.12 | $40.15 |
| Average True Range (ATR) | 0.28 | 1.22 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 3.14 | 69.27 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.